Private Insurers Offering Medicare Prescription Drug Plans Do Not Receive ‘Significant’ Discounts From Drug Makers, Wall Street Journal Reports
Nearly $15 billion could have been saved this year if private insurers that offer Medicare prescription drug plans had administrative costs similar to those of Medicare and if they obtained discounts on drugs similar to those received by Medicaid, according to a report commissioned by House Oversight and Government Reform Committee Chair Henry Waxman (D-Calif. [click link for full article]
Recent Comments